Rogue antibodies could be driving severe COVID-19

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science · doi:10.1126/science.abd4585 · Cited by 2,662 · see citing works

Diverse functional autoantibodies in patients with COVID-19

Wang, E. Y., Mao, T., Klein, J., Dai, Y., Huck, J. D., Jaycox, J. R., Liu, F., Zhou, T., Israelow, B., Wong, P., et al. (2021) · Nature · doi:10.1038/s41586-021-03631-y · Cited by 999 · see citing works

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

Zuo, Y., Estes, S. K., Ali, R. A., Gandhi, A. A., Yalavarthi, S., Shi, H., Sule, G. J., Gockman, K., Madison, J. A., Zuo, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3876 · Cited by 658 · see citing works

Covid-19 and autoimmunity

Ehrenfeld, M., Tincani, A., Andréoli, L., Cattalini, M., Greenbaum, A., Kanduc, D., Alijotas‐Reig, J., Zinserling, V. A., Semenova, N. Y., Amital, H., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102597 · Cited by 565 · see citing works

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Monk, P., Marsden, R., Tear, V. J., Brookes, J. L., Batten, T. N., Mankowski, M., Gabbay, F. J., Davies, D. E., Holgate, S. T., Ho, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30511-7 · Cited by 431 · see citing works

Immune Thrombocytopenic Purpura in a Patient with Covid-19

Zulfiqar, A., Lorenzo-Villalba, N., Hassler, P., & Andrès, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010472 · Cited by 320 · see citing works

Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review

Bhattacharjee, S., & Banerjee, M. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00521-8 · Cited by 289 · see citing works

Diverse Functional Autoantibodies in Patients with COVID-19Preprint

Wang, E. Y., Mao, T., Klein, J., et al. (2020) · medRxiv · doi:10.1101/2020.12.10.20247205 · Cited by 205 · see citing works

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary reportPreprint

The REMAP-CAP Investigators, Gordon, A. C., Mouncey, P. R., Al-Beidh, F., Rowan, K., Nichol, A., Arabi, Y. M., Annane, D., Beane, A., van Bentum-Puijk, W., et al. (2021) · medRxiv · doi:10.1101/2021.01.07.21249390 · Cited by 130 · see citing works

Characteristics of Autoantibodies to Human Interferon in a Patient with Varicella-Zoster Disease

Pozzetto, B., Mogensen, K. E., Tovey, M. G., & Gresser, I. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/150.5.707 · Cited by 104 · see citing works

Autoimmunity to annexin A2 predicts mortality among hospitalised COVID-19 patients

Zuniga, M., Gomes, C., Carsons, S. E., Bender, M. T., Cotzia, P., Miao, Q., Lee, D. C., & Rodrı́guez, A. (2021) · European Respiratory Journal · doi:10.1183/13993003.00918-2021 · Cited by 86 · see citing works

Autoimmunity to the Lung Protective Phospholipid-Binding Protein Annexin A2 Predicts Mortality Among Hospitalized COVID-19 PatientsPreprint

Zuniga, M., Gomes, C., Carsons, S. E., et al. (2021) · medRxiv · doi:10.1101/2020.12.28.20248807 · Cited by 34 · see citing works

The Lancet Commission on lessons for the future from the COVID-19 pandemic

Sachs, J. D., Karim, S. S. A., Aknin, L., Allen, J., Brosbøl, K., Colombo, F., Barron, G. C., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01585-9 · Cited by 842 · see citing works

Pathophysiology of COVID-19-associated acute kidney injury

Legrand, M. M., Bell, S., Forni, L. G., Joannidis, M., Koyner, J. L., Liu, K. D., & Cantaluppi, V. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00452-0 · Cited by 508 · see citing works

Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms

Wallukat, G., Hohberger, B., Wenzel, K., Fürst, J., Schulze-Rothe, S., Wallukat, A., Hönicke, A.-S., & Müller, J. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100100 · Cited by 368 · see citing works

Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study

Osmanov, I. M., Spiridonova, E., Bobkova, P., Gamirova, A., Shikhaleva, A., Andreeva, M., Blyuss, O. B., El-Taravi, Y., DunnGalvin, A., Comberiati, P., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01341-2021 · Cited by 341 · see citing works

Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review

Sylvester, S. V., Rusu, R., Chan, B., Bellows, M., O’Keefe, C., & Nicholson, S. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2081454 · Cited by 280 · see citing works

Two Cases of Graves' Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants

Lastra, O. L. V., Navarro, A. O., Cruz-Domínguez, M. P., Medina, G., Valadez, T. I. S., & Jara, L. J. (2021) · Thyroid · doi:10.1089/thy.2021.0142 · Cited by 202 · see citing works

Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity

Cabral-Marques, O., Halpert, G., Schimke, L. F., Ostrinski, Y., Vojdani, A., Baiocchi, G. C., Freire, P. P., Filgueiras, I. S., Zyskind, I., Lattin, M. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28905-5 · Cited by 142 · see citing works

Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity

Sotzny, F., Filgueiras, I. S., Kedor, C., Freitag, H., Wittke, K., Bauer, S., Sepúlveda, N., Fonseca, D. L. M., Baiocchi, G. C., Marques, A. H. C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.981532 · Cited by 107 · see citing works

Sexual dimorphism in COVID-19: potential clinical and public health implications

Bechmann, N., Barthel, A., Schedl, A., Herzig, S., Varga, Z., Gebhard, C., Mayr, M., Hantel, C., Beuschlein, F., Wolfrum, C., et al. (2022) · Publikationen an der Universität Bielefeld (Universität Bielefeld) · Cited by 110 · see citing works

Sexual dimorphism in COVID-19: potential clinical and public health implications

Bechmann, N., Barthel, A., Schedl, A., Herzig, S., Varga, Z., Gebhard, C., Mayr, M., Hantel, C., Beuschlein, F., Wolfrum, C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00346-6 · Cited by 116 · see citing works

Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy

Ortona, E., & Malorni, W. (2021) · European Respiratory Journal · doi:10.1183/13993003.02245-2021 · Cited by 106 · see citing works

Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis

Rivas, M. N., Porritt, R. A., Cheng, M. H., Bahar, İ., & Arditi, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941009 · Cited by 106 · see citing works

Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?

Bornstein, S. R., Voit-Bak, K., Donate, T., Rodionov, R. N., Gainetdinov, R. R., Tselmin, S., Kanczkowski, W., Müller, G. M., Achleitner, M., Wang, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01148-4 · Cited by 85 · see citing works

Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation

Ito, T., Kakuuchi, M., & Maruyama, I. (2021) · Critical Care · doi:10.1186/s13054-021-03524-6 · Cited by 63 · see citing works

Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS

Morrow, A. K., Malone, L. A., Kokorelis, C., Petracek, L. S., Eastin, E. F., Lobner, K. L., Neuendorff, L., & Rowe, P. C. (2022) · Current Pediatrics Reports · doi:10.1007/s40124-022-00261-4 · Cited by 59 · see citing works

Vascular “Long COVID”: A New Vessel Disease?

Zanini, G., Selleri, V., Roncati, L., Coppi, F., Nasi, M., Farinetti, A., Manenti, A., Pinti, M., & Mattioli, A. V. (2023) · Angiology · doi:10.1177/00033197231153204 · Cited by 66 · see citing works

Long COVID: an estrogen-associated autoimmune disease?

Ortona, E., Buonsenso, D., Carfì, A., Malorni, W., The Long Covid Kids study group, Munblit, D., Rose, C. D., Sinatti, D., Ricchiuto, A., & Valentini, P. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00464-6 · Cited by 60 · see citing works

SARS-CoV-2 involvement in central nervous system tissue damage

Sabra, M., Kobeissy, F. H., Bizri, M., Haidar, M. A., Shakkour, Z., Reslan, M. A., Al-Haj, N., Chamoun, P., Habashy, K. J., Kaafarani, H., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.327323 · Cited by 57 · see citing works

Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review

Louis, T. J., Qasem, A., Abdelli, L. S., & Naser, S. A. (2022) · Microorganisms · doi:10.3390/microorganisms10010153 · Cited by 50 · see citing works

Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium

Cabral-Marques, O., Moll, G., Catar, R. A., Preuß, B. E., Bankamp, L., Pecher, A., Henes, J., Klein, R., Kamalanathan, A. S., Akbarzadeh, R., et al. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103310 · Cited by 48 · see citing works

Autoantibodies - enemies, and/or potential allies?

Ma, H., Murphy, C., Loscher, C. E., & O’Kennedy, R. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953726 · Cited by 43 · see citing works

The relationship between chronic immune response and neurodegenerative damage in long COVID-19

Elizalde-Díaz, J. P., Miranda-Narváez, C. L., Martínez‐Lazcano, J. C., & Martínez‐Martínez, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039427 · Cited by 41 · see citing works

Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach

Fonseca, D. L. M., Filgueiras, I. S., Marques, A. H. C., Vojdani, E., Halpert, G., Ostrinski, Y., Baiocchi, G. C., Plaça, D. R., Freire, P. P., Pour, S. Z., et al. (2023) · npj Aging · doi:10.1038/s41514-023-00118-0 · Cited by 48 · see citing works

COVID-19 Immunobiology: Lessons Learned, New Questions Arise

Kaklamanos, A., Belogiannis, K., Skendros, P., Gorgoulis, V. G., Vlachoyiannopoulos, P. G., & Tzioufas, A. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719023 · Cited by 37 · see citing works

Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications

Patil, P., Shetty, P. K., Kuriakose, N., Gollapalli, P., Shetty, S., Bhandary, R. R., Vishwanatha, J. K., & Ghate, S. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011028 · Cited by 33 · see citing works

Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody

Nguyen, H. V., Lan, P. D., Nissley, D. A., O’Brien, E. P., & Li, M. S. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c03639 · Cited by 32 · see citing works

Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions

Müller, L., & Benedetto, S. D. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00341-z · Cited by 31 · see citing works

A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance

Karim, M. A., Shilts, J., Schwartzentruber, J., Hayhurst, J. D., Buniello, A., Mohammed, E. S. E., Zheng, J., Holmes, M. V., Ochoa, D., Carmona, M., et al. (2021) · eLife · doi:10.7554/elife.69719 · Cited by 28 · see citing works

Post-COVID syndrome: the aftershock of SARS-CoV-2

Dotan, A., & Shoenfeld, Y. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.11.020 · Cited by 27 · see citing works

Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches

Sodagar, A., Javed, R., Tahir, H., Razak, S. I. A., Shakir, M., Naeem, M., Yusof, A. H. A., Sagadevan, S., Hazafa, A., Uddin, J., et al. (2022) · Biomolecules · doi:10.3390/biom12070971 · Cited by 27 · see citing works

Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence

L’Huillier, A. G., Pagano, S., Baggio, S., Meyer, B., Andrey, D. O., Nehme, M., Guessous, I., Eberhardt, C. S., Huttner, A. C., Posfay-Barbe, K. M., et al. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13818 · Cited by 26 · see citing works

Immunodominant antibody germlines in COVID-19

Andreano, E., & Rappuoli, R. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210281 · Cited by 25 · see citing works

Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity

Baiocchi, G. C., Vojdani, A., Rosenberg, A. Z., Vojdani, E., Halpert, G., Ostrinski, Y., Zyskind, I., Filgueiras, I. S., Schimke, L. F., Marques, A. H. C., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28538 · Cited by 24 · see citing works

Annexin A2: the missing piece in the puzzle of pathogen-induced damage

Li, C., Yu, J., Liao, D., Su, X., Yi, X., Yang, X. F., & He, J. (2023) · Virulence · doi:10.1080/21505594.2023.2237222 · Cited by 23 · see citing works

COVID-19 ‘asymptomatic’ patients: an old wives’ tale

Mouliou, D. S., & Gourgoulianis, K. I. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2030224 · Cited by 22 · see citing works

Immune system changes in those with hypertension when infected with SARS-CoV-2

Su, S., Chen, R., Zhang, S., Shu, H., & Luo, J. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104562 · Cited by 22 · see citing works

Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection

Chen, C., Amelia, A. R., Ashdown, G. W., Müeller, I., Coussens, A. K., & Eriksson, E. M. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00422-z · Cited by 20 · see citing works

Long Covid: Untangling the Complex Syndrome and the Search for Therapeutics

Haque, A., & Pant, A. B. (2022) · Viruses · doi:10.3390/v15010042 · Cited by 18 · see citing works

Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients

Lichter, Y., Badelbayov, T., Shalev, I., Schvartz, R., Szekely, Y., Benisty, D., Goldiner, I., Kagarlyk, M., Asraf, K., Doolman, R., et al. (2021) · Thrombosis Journal · doi:10.1186/s12959-021-00333-3 · Cited by 16 · see citing works

Mass spectrometry-based autoimmune profiling reveals predictive autoantigens in idiopathic pulmonary fibrosis

Leuschner, G., Semenova, A., Mayr, C. H., Kapellos, T. S., Ansari, M., Seeliger, B., Frankenberger, M., Kneidinger, N., Hatz, R. A., Hilgendorff, A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108345 · Cited by 16 · see citing works

SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1

Pagano, S., Yerly, S., Meyer, B., Juillard, C., Suh, N., Terrier, C. L., Daguer, J., Soler, L. F., Barluenga, S., Piumatti, G., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13661 · Cited by 15 · see citing works

SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study

Luchetti, M. M., Paci, V., Marconi, V., Gigli, M., Benfaremo, D., Sordillo, R., Macchini, C., Massaccesi, L., Perna, G. P., Offidani, A. M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859550 · Cited by 15 · see citing works

Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019

Khorramdelazad, H., Kazemi, M. H., Azimi, M., Aghamajidi, A., Mehrabadi, A. Z., Shahba, F., Aghamohamadi, N., Falak, R., Faraji, F., & Jafari, R. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175051 · Cited by 15 · see citing works

A Prospect to Ameliorate Affective Symptoms and to Enhance Cognition in Long COVID Using Auricular Transcutaneous Vagus Nerve Stimulation

Colzato, L. S., Elmers, J., Beste, C., & Hommel, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031198 · Cited by 13 · see citing works

COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts

Välikangas, T., Junttila, S., Rytkönen, K. T., Kukkonen-Macchi, A., Suomi, T., & Elo, L. L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.929887 · Cited by 12 · see citing works

European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19

Crook, H., Ramı́rez, A., Hosseini, A. A., Vavougios, G. D., Lehmann, C., Bruchfeld, J., Schneider, A., d’Avossa, G., Re, V. L., Salmoiraghi, A., et al. (2023) · Brain Connectivity · doi:10.1089/brain.2022.0058 · Cited by 12 · see citing works

Graves' Disease after Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in a Type 1 Diabetes Patient

Sakai, M., Takao, K., Kato, T., Ito, K., Kubota, S., Hirose, T., Liu, Y., Mizuno, M., Hirota, T., Suwa, T., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.9231-21 · Cited by 11 · see citing works

Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19Preprint

Thurner, L., Fadle, N., Bewarder, M., Kos, I. A., Regitz, E., Thurner, B., Fischer, Y., Cetin, O., Rixecker, T. M., Hoffmann, M.-C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.23.441188 · Cited by 11 · see citing works

Impact of Annexin A2 on virus life cycles

Park, I.-W., Fiadjoe, H. K., & Chaudhary, P. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199384 · Cited by 10 · see citing works

SARS-CoV-2 and human retroelements: a case for molecular mimicry?

Koch, B. (2022) · BMC Genomic Data · doi:10.1186/s12863-022-01040-2 · Cited by 10 · see citing works

Pathophysiology of COVID-19-Associated Neurotoxicity

Cascella, M., & Blasio, E. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-86705-8_1 · Cited by 8 · see citing works

Crosstalk between COVID-19 Infection and Kidney Diseases: A Review on the Metabolomic Approaches

Murali, R., Wanjari, U. R., Mukherjee, A. G., Gopalakrishnan, A. V., Kannampuzha, S., Namachivayam, A., Madhyastha, H., Renu, K., & Ganesan, R. (2023) · Vaccines · doi:10.3390/vaccines11020489 · Cited by 8 · see citing works

Aptamer BC 007’s Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies

Haberland, A., Krylova, O. O., Nikolenko, H., Göttel, P., Dallmann, A., Müller, J., & Weisshoff, H. (2021) · Viruses · doi:10.3390/v13050932 · Cited by 8 · see citing works

Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools

Liu, S., Li, Q., Chu, X., Zeng, M., Liu, M., He, X., Zou, H., Zheng, J., Corpe, C. P., Zhang, X., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.672215 · Cited by 8 · see citing works

Identifying inhibitors of NSP16-NSP10 of SARS-CoV-2 from large databases

Nguyen, H. L., Thai, N. Q., & Li, M. S. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2114941 · Cited by 7 · see citing works

Functional Capacity in Patients Who Recovered from Mild COVID-19 with Exertional Dyspnea

Dotan, Y., Weiner, E., Zucker‐Toledano, M., Solomonov, A., Fuchs, E., Dawood, H., Mor, E., Hanna, M., Naser-Aldeen, R., Bentur, L., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060874 · Cited by 6 · see citing works

COVID-19 and Multiorgan Dysfunction Syndrome

Lakhani, J. D., Kapadia, S., Choradiya, R., Gill, R., & Lakhani, S. J. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99676 · Cited by 6 · see citing works

Revealing the Hidden Impacts: Insights into Biological Aging and Long-Term Effects in Pauci- and Asymptomatic COVID-19 Healthcare Workers

Campisi, M., Cannella, L., Bordin, A., Moretto, A., Scapellato, M. L., Mason, P., Liviero, F., Pavanello, S., & on behalf of Occupational Medicine Working Group (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158056 · Cited by 5 · see citing works

Two cases of systemic lupus erythematosus after administration of severe acute respiratory syndrome coronavirus 2 vaccine

Sakai, M., Takao, K., Mizuno, M., Ando, H., Kawashima, Y., Kato, T., Kubota, S., Hirose, T., Hirota, T., Horikawa, Y., et al. (2023) · Modern Rheumatology Case Reports · doi:10.1093/mrcr/rxad008 · Cited by 5 · see citing works

Autoantibodies linked to autoimmune diseases associate with COVID-19 outcomesPreprint

Baiocchi, G. C., Vojdani, A., Rosenberg, A. Z., Vojdani, E., Halpert, G., Ostrinski, Y., Zyskind, I., Filgueiras, I. S., Schimke, L. F., Marques, A. H. C., et al. (2022) · medRxiv · doi:10.1101/2022.02.17.22271057 · Cited by 5 · see citing works

Rarely Recognized Antibody Diversification in Covid-19 Evolution to Counteract Advanced SARS-CoV-2 Evasion Strategies, and Implications for Prophylactic Treatment

Mueller, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.624675 · Cited by 4 · see citing works

Neurological, Psychological, and Cognitive Manifestations of Long-COVID

Cascella, M., & Blasio, E. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-86705-8_4 · Cited by 4 · see citing works

Passive antibody therapy in emerging infectious diseases

Yang, X. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1021-y · Cited by 3 · see citing works

Long-term COVID-19 sequelae by Theta and SARS-CoV-2 variants in a Philippine cohort

Saloma, C. P., Ayes, M. E. C., Taracatac, P. S., & Meryl Rose, Q. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1455729 · Cited by 3 · see citing works

The age-dependent neuroglial interaction with peripheral immune cells in coronavirus-induced neuroinflammation with a special emphasis on COVID-19

Ghosh, S., & Sarma, J. D. (2025) · Biogerontology · doi:10.1007/s10522-025-10252-9 · Cited by 3 · see citing works

Aptamers Against COVID-19: An Untested Opportunity

Haberland, A., & Müller, J. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220112094951 · Cited by 3 · see citing works

Beginnings of coinhibition

Sinclair, N. R. S. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13098 · Cited by 2 · see citing works

Lack of efficacy of mono‐mode of action therapeutics in COVID‐19 therapy ‐ How the lack of predictive power of preclinical cell and animal studies leads developments astray

Haberland, A., & Müller, J. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13954 · Cited by 2 · see citing works

Diplopia, COVID-19 and Vaccination: Results from a Cross-Sectional Study in Croatia

Herman, J. Š., Marić, G., Ravlić, M. M., Knežević, L., Jerković, I., Sušić, E., Marić, V., Vicković, I. P., Vatavuk, Z., & Polašek, O. (2022) · Vaccines · doi:10.3390/vaccines10091558 · Cited by 1 · see citing works

An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay

Ho, A. D., Verkerke, H., Allen, J. W. L., Saeedi, B. J., Boyer, D., Owens, J. A., Shin, S., Horwath, M. C., Patel, K., Paul, A., et al. (2021) · Immunohematology · doi:10.21307/immunohematology-2021-007 · Cited by 1 · see citing works

The Search for Immunological Biomarkers in Type 1 Diabetes Mellitus (T1DM) and Multiple Sclerosis (MS): Th40 Cells Provide a Common Autoimmune Link

Wagner, D. H. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_29 · Cited by 1 · see citing works

A proteomics workflow reveals predictive autoantigens in idiopathic pulmonary fibrosisPreprint

Leuschner, G., Mayr, C. H., Ansari, M., Seeliger, B., Frankenberger, M., Kneidinger, N., Hatz, R. A., Hilgendorff, A., Prasse, A., Behr, J., et al. (2021) · medRxiv · doi:10.1101/2021.02.17.21251826 · Cited by 1 · see citing works

Xenosialylation: Role in SARS/CoV-2 Post-infectious and Post-vaccination Complications and Common Cause of Hyperimmune/Autoimmune DiseasesPreprint

Carnevali, F., Mangiaterra, S., & Rossi, G. (2023) · Preprints.org · doi:10.20944/preprints202310.0001.v1 · Cited by 1 · see citing works

Xenosialylation: Role in SARS/CoV-2 Post-infectious and Post-vaccination Complications and Common Cause of Hyperimmune/Autoimmune DiseasesPreprint

Carnevali, F., Mangiaterra, S., & Rossi, G. (2023) · Preprints.org · doi:10.20944/preprints202310.0001.v2 · Cited by 1 · see citing works

Lehetőségek és buktatók a SARS-CoV-2-antigén és az ellene termelt antitestek kimutatásában

Medgyaszai, M., Péterfi, Z., & Valkó, A. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32210

TCA-soluble blood serum proteins of COVID-19 patients as possible predictive markers for the disease severityPreprint

Orfin, А. Y., Starykovych, M. O., Alexanyan, T., Tkachuk, S., Starodub, A., Luchyshyn, T., Sibirny, A. А., Souchelnytskyi, S., & Kit, Y. Y. (2021) · medRxiv · doi:10.1101/2021.04.07.21255063

Computational genomic analysis of the lung tissue microenvironment in COVID-19 patientsPreprint

Bhuvaneshwar, K., Madhavan, S., & Gusev, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.28.446250

Antinuclear Autoimmunity Potentially Makes the Middle-aged and Female with COVID-19 Prone to Severe Progression: A Case-control StudyPreprint

Cao, Z., Zhou, F., Zhang, J., Chen, C., Zhao, Z., Chen, T., Liang, K., Wu, K., Cheng, Z., Peng, Z., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-806396/v1

Neuroimmunology and Neurological Manifestations of COVID-19

Weissert, R. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103026

The Search for Immunological Biomarkers in Type 1 Diabetes Mellitus (T1DM) and Multiple Sclerosis (MS): Th40 Cells Provide a Common Autoimmune Link

Wagner, D. H. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_29-1

Predicting Risk of Emerging Cardiotoxicity

Goins, M., Lovell, K. K., Keel, G., Cook, J. L., & Lust, R. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105040

PULMONARY FUNCTIONS AND IMMUNOLOGICAL RESPONSE AMONG HEALTH CARE WORKERS RECOVERED FROM COVID-19 INFECTION COMPARED TO THEIR COUNTERPARTS WITHOUT PREVIOUS INFECTION

Shaker, D. A.-H., Zaky, R. A., Salem, S. T., & Mourad, B. H. (2023) · Egyptian Journal of Occupational Medicine · doi:10.21608/ejom.2022.134720.1273

Autoantibodies neutralizing antiinflammatory mediators in the context of SARS-CoV-2 infection and COVID-19

Thurner, L., & Kessel, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00031-1

Crossroads between Autoimmunity and COVID-19 in Lung Transplant Recipients

Narasimhan, M., Muthukumar, A., Sataranatarajan, K., Mahimainathan, L., Mahan, L. D., Timofte, I., Bollineni, S., JOERNS, J. O., Zhang, S., Gorman, A., et al. (2023) · Viruses · doi:10.3390/v15102045

Análise compreensiva da resposta imune às infecções por ZIKV e SARS-CoV-2 em diferentes contextos patológicos

Filgueiras, I. S. (2023) · doi:10.11606/d.42.2023.tde-02102023-145903

Pandemieforschung: von Autoantikörpern und Impfstoff-Innovationen

de la Rosa, K. (2023) · BIOspektrum · doi:10.1007/s12268-023-2000-1

dentification of some variable parameters in serum of COVID-19 patients in comparison with control group

Salim, M. M. (2024) · Egyptian journal of Immunology · doi:10.55133/eji.310202

A Viral Pedagogy: Undoing Things with Long COVID’s Autoimmunities

Varino, S. (2024) · Catalyst Feminism Theory Technoscience · doi:10.28968/cftt.v10i2.40289

Integrative genomic analysis of the lung tissue microenvironment in SARS-CoV-2 and NL63 patients

Bhuvaneshwar, K., Madhavan, S., & Gusev, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32772

Role of Xenosialylation in Post-Infectious and Post-Vaccination Complications, Including Covid-19 and Anti-SARS-CoV-2 Vaccination

Carnevali, F., Mangiaterra, S., & Rossi, G. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s471093

Additional file 3 of Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation

Ito, T., Kakuuchi, M., & Maruyama, I. (2021) · Figshare · doi:10.6084/m9.figshare.14183577

Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity

Baiocchi, G. C., Vojdani, A., Rosenberg, A. Z., Vojdani, E., Halpert, G., Ostrinski, Y., Zyskind, I., Filgueiras, I. S., Schimke, L. F., Marques, A. H. C., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28538 · Cited by 24 · see citing works

JUNG'S PSYCHOTHERAPY

Bennet, E. A. (1955) · BMJ · doi:10.1136/bmj.1.4912.524-c

Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection

Chen, C., Amelia, A. R., Ashdown, G. W., Müeller, I., Coussens, A. K., & Eriksson, E. M. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00422-z · Cited by 20 · see citing works

Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens

Ulndreaj, A., Wang, M., Misaghian, S., Paone, L. S., Sigal, G. B., Stengelin, M. K., Campbell, C., Nynatten, L. R. V., Soosaipillai, A. R., Ghorbani, A., et al. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0239 · Cited by 3 · see citing works

Autoantibodies in COVID-19: implications for disease severity and clinical outcomes

Galipeau, Y., Cooper, C., & Langlois, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1509289 · Cited by 18 · see citing works